邢 艳,吴玉梅.局部晚期宫颈癌新辅助化疗研究进展[J].肿瘤学杂志,2014,20(12):967-971.
局部晚期宫颈癌新辅助化疗研究进展
Progress in Neoadjuvant Chemotherapy in the Treatment for Locally Advanced Cervical Cancer
投稿时间:2014-06-29  
DOI:10.11735/j.issn.1671-170X.2014.12.B001
中文关键词:  宫颈肿瘤  新辅助化疗  介入化疗  疗效评价
英文关键词:cervical neoplasms  neoadjuvant chemotherapy  interventional chemotherapy  efficacy evaluation
基金项目:
作者单位
邢 艳 首都医科大学附属北京妇产医院 
吴玉梅 首都医科大学附属北京妇产医院 
摘要点击次数: 1911
全文下载次数: 945
中文摘要:
      摘 要:宫颈癌发病率位居女性常见恶性肿瘤第2位,全球最常见恶性肿瘤第5位。超过35%的宫颈癌诊断时已达局部晚期,即Ⅰb2~Ⅱb期,5年总生存率约为60%。在欧洲、亚洲及拉丁美洲一些国家,新辅助化疗联合根治性手术已成为一线治疗方案。新辅助化疗作为一项新的治疗方法,其具体治疗方案、适应证及疗效评价仍需进一步研究。本文将针对局部晚期宫颈癌新辅助化疗的目的、方案、适应证、疗效等方面进行综述。
英文摘要:
      Abstract:Cervical cancer is the second most common cancer in women,the fifth most common malignancy in the world. It is estimated that over 35% of tumors are at locally advanced stage(stageⅠb2~Ⅱb) when diagnosed with an estimated 5-year overall survival of 60%.Neoadjuvant chemotherapy combined with radical surgery is the first line treatment in some countries of Europe,Asia and Latin America.Neoadjuvant chemotherapy as a new treatment,the specific procedure,indications and therapeutic evaluation needs to be studied further. This article summarizes from the principle,methods,indications,efficacy of neoadjuvant chemotherapy in the treatment for locally advanced cervical cancer.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器